The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
about
Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathyModulation of glucose metabolism by the renin-angiotensin-aldosterone systemAdvanced glycation end products and diabetic complicationsActivation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix productionThe effect of chronic candesartan therapy on the metabolic profile and renal tissue cytokine levels in the obese Zucker rat.3',4'-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 ratsHyperglycemia and blood pressure treatment goal: a cross sectional survey of 18350 patients with type 2 diabetes in 77 tertiary hospitals in China.Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusMineralocorticoid receptor antagonists and the metabolic syndromeAldosterone antagonists in monotherapy are protective against streptozotocin-induced diabetic nephropathy in rats.Metabolic syndrome: definitions and controversies.Effects of Losartan vs. Enalapril on the Markers of Metabolic Syndrome.Intracardiac intracellular angiotensin system in diabetes.Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation.Ferulsinaic Acid Modulates SOD, GSH, and Antioxidant Enzymes in Diabetic KidneyVisceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterationsInhibition of renin activity slows down the progression of HIV-associated nephropathyMultidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.Do ACE I/D gene polymorphism serve as a predictive marker for age at onset in PCOS?Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT).Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.Why is blood pressure so hard to control in patients with type 2 diabetes?Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity.Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axisThe renin-angiotensin system and diabetes: an update.Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.Application of direct renin inhibition to chronic kidney disease.The role of angiotensin receptor blockers in diabetic nephropathy.Metabolic syndrome in patients with hematological diseases.The effect of RAAS blockade on the progression of diabetic nephropathy.The role of novel biomarkers in predicting diabetic nephropathy: a review.New molecular insights in diabetic nephropathy.The Blocking on the Cathepsin B and Fibronectin Accumulation in Kidney Glomeruli of Diabetic RatsThe Effect of Regular Moderate Exercise on miRNA-192 Expression Changes in Kidney of Streptozotocin-Induced Diabetic Male Rats.Effects of Azilsartan, Aliskiren or their Combination on High Fat Diet-induced Non-alcoholic Liver Disease Model in Rats.Angiotensin receptor blockade improves cardiac mitochondrial activity in response to an acute glucose load in obese insulin resistant rats.Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats.Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism.Effect of captopril and the bradykinin-PKC pathway on ROS production in type 1 diabetic rats.The effects of spironolactone on nephron function in patients with diabetic nephropathy.
P2860
Q26799594-F6CD84D2-56AF-47C4-B3DA-DA36429ACFFFQ27026157-BAC5B4E4-35B9-422B-AA2F-E23E12829F49Q27687501-4DFEFB2B-BFD8-4DA5-BFB3-5A57DF3F5EBDQ28269927-172CF3DC-6934-44B5-898F-833CB545F5A6Q33861166-4E4AA5DC-9B7E-417F-86A8-7F913B8B6D1EQ33987863-2D612E57-0FAE-4323-927C-8D136E58121AQ34046606-BBE55189-B5F7-4F22-BDF9-AAA6C08F52ACQ34124779-337568D7-31F8-4BA4-9190-7A701C5081F9Q34168923-031AC5F9-385B-4FFA-98C9-9E3A616AC62BQ34326639-8D662761-B852-4EBD-8A68-B23B64EA5796Q35047747-2A320FA6-1CB0-453E-A92D-0459AC12E85AQ35764519-AB81DB0D-0091-4851-A0FC-9FD163B9401EQ35850260-F9D4411B-1111-47C8-8679-AA9359EC811EQ35924401-8D450E00-6659-4C66-848D-D7F3E35E1D88Q36237698-D2A44293-5B34-4DFB-956A-61920CADB393Q36297722-BD638946-2713-4FB7-823D-6593AAFA7C02Q36309378-3CEC62AC-0C7F-4579-B2FA-AFAA0518754BQ36470320-2EB2EF30-611D-4FD1-8F0F-60AAFE892924Q36557299-707320D0-254B-44E5-934D-6DFF0D66A315Q36807421-48D61334-C68B-4CD2-B67D-9E1AF17A2604Q36892489-179D39DC-53FF-46C4-AC53-A0F9B3A81790Q36904456-26D32823-760A-48BD-B59A-3FB06E93CF34Q36958256-01B6D8B2-3E2D-48B1-9EDD-CC4526F19970Q37101896-CD54F27D-AA63-4ED2-83D1-C48AD0725235Q37344441-DF4F724D-F594-4880-8FE2-86E9288C9D10Q37503374-C88BB270-6EE1-476C-9F37-7A9146DD7849Q37758534-FA1C9E14-84EA-4F22-B241-7DC1D38DD94DQ37874892-C8F94D23-4D22-452B-B486-CA930FD3703AQ38044776-6407108B-3033-4229-8D2C-B3E54421E9BDQ38168046-62140B5B-5830-4166-8232-113FBE5A599DQ38598929-174E8DB7-69DB-417D-84E8-7155BEA22502Q38694219-5C13E18A-A846-4F23-881E-6188AC2B84A1Q41552405-7C45D1AA-901B-4822-A139-6D2A28EA3788Q42012842-B45A42BD-FA8A-46CB-A6D2-E7170FF1E3F1Q42354239-38083FCE-701E-4EB4-AEDA-BDBCAC1EE90CQ42380235-199B9138-280D-4FE3-AE39-7D74496D50F7Q42535798-05A45795-60AF-4A81-9E30-74EA6ADFEBFFQ44064473-E9433CEB-A47D-46DD-835F-54B1AF7D7825Q45901856-8CEC37C8-A5D4-4702-8FC8-7C79C8D002D6Q46240721-BD9BCD9B-DA13-4853-8E7E-89D180BEFC9F
P2860
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
@ast
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
@en
type
label
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
@ast
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
@en
prefLabel
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
@ast
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
@en
P2093
P1476
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
@en
P2093
Leonardo A Sechi
Robert M Carey
Silvia Rilli
P304
P356
10.1016/J.TEM.2005.02.003
P577
2005-04-01T00:00:00Z